Banks are gearing up to offload the €8.65 billion ($9.5 billion) debt package backing Clayton Dubilier & Rice’s purchase of a ...
Sanofi Pasteur and Merial will continue as Sanofi's vaccines and animal health products divisions, respectively, headed by their current bosses Olivier Charmeil and Carsten Hellmann. Sanofi has ...
Sanofi (SNY) announced the immediate adoption of influenza strains selected by the Food and Drug Administration to advance the manufacturing ...
13d
The Manila Times on MSNPAO: Garin withheld Dengvaxia's fatal risksTHE Public Attorney's Office (PAO) told a Quezon City-Regional Trial Court that the death of many children allegedly due to ...
Sanofi’s sale of its $17bn consumer health business Opella just advanced a step closer, after the drugmaker signed a share purchase agreement with buyer Clayton Dubilier & Rice (CD&R).
12d
HealthDay on MSNAt-Home Light-Emitting Diode Devices Safe, Effective for Acne Treatmentparticularly those that combine red and blue light, are efficacious for acne and can likely complement other over-the-counter ...
Sanofi has shared a deeper dive into its 469 million euro ($491 million) bowel disease bet, publishing phase 2 data that provide a clearer look at how the Teva-partnered prospect compares to Merck ...
Sanofi's deep partnership with OpenAI could be a huge differentiating factor as OpenAI's agentic models grow in capabilities. OpenAI's "Deep Research" tool is already incredibly promising for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results